Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
Public ClinicalTrials.gov record NCT05893537. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, prospective, multicenter, randomized, double-masked, placebo-controlled 104-week study to assess the efficacy, safety, and tolerability of orally delivered CT1812 compared to placebo in participants with GA associated with dry AMD.
Study identification
- NCT ID
- NCT05893537
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2023 (Actual)
- Primary completion
- Mar 4, 2025 (Actual)
- Completion
- Mar 28, 2025 (Actual)
- Last update posted
- Apr 16, 2025
2023 – 2025
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Retina Associates | Phoenix | Arizona | 85050 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95825 | — |
| Bay Area Retina Associates | Walnut Creek | California | 94598 | — |
| Advanced Research | Deerfield Beach | Florida | 33064 | — |
| Rand Eye Institute | Deerfield Beach | Florida | 33064 | — |
| National Ophthalmic Research Institute | Fort Myers | Florida | 11735 | — |
| Center for Retina and Macular Disease | Winter Haven | Florida | 33880 | — |
| Retina Specialists | Baltimore | Maryland | 21204 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| NJ Retina | Edison | New Jersey | 08820 | — |
| Long Island Vitreoretinal Consultants | Great Neck | New York | 11021 | — |
| North Carolina Retina Associates | Wake Forest | North Carolina | 27587 | — |
| Verum Research LLC | Eugene | Oregon | 97401 | — |
| Erie Retina Research, LLC | Erie | Pennsylvania | 16507 | — |
| Tennessee Retina, PC | Nashville | Tennessee | 37203 | — |
| Austin Clinical Research, LLC | Austin | Texas | 78750 | — |
| Star Vision Consultants | Burleson | Texas | 76028 | — |
| Texas Retina Associates | Fort Worth | Texas | 76104 | — |
| Retina Consultants of Texas | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05893537, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05893537 live on ClinicalTrials.gov.